Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Phuchareon, Janyaporn ^a,b   Ohta, Yoshihito ^a,b   Woo, Jonathan M ^c   Eisele, David W ^a,b   Tetsu, Osamu ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMELOGENIN; CYTOCHROME C OXIDASE;

ADENOID CYSTIC CARCINOMA; ANIMAL CELL; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL LABELING; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ERROR; DNA FINGERPRINTING; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; HUMAN; HUMAN CELL; NONHUMAN; RAT; SHORT TANDEM REPEAT; UTERINE CERVIX CANCER; ALLELE; ANIMAL; BLADDER TUMOR; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; MOUSE; SALIVARY GLAND TUMOR; TUMOR CELL LINE;

MAMMALIA; RATTUS;

ALLELES; ANIMALS; CARCINOMA, ADENOID CYSTIC; CELL LINE, TUMOR; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; RATS; SALIVARY GLAND NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 67649494469     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006040     Document Type: Article

References (47)

1. Seifert G, Brocheriou C, Cardesa A, Eveson JW, WHO International Histological Classification of Tumours (1990) Tentative Histological Classification of Salivary Gland Tumours. Pathol Res Pract 186: 555-81.
2. Chummun S, McLean NR, Kelly CG, Dawes PJ, Meikle D, et al. (2001) Adenoid cystic carcinoma of the head and neck. Br J Plast Surg 54: 476-80.
3. Bradley PJ (2004) Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 12: 127-32.
4. Khafif A, Anavi Y, Haviv J, Fienmesser R, Calderon S, et al. (2005) Adenoid cystic carcinoma of the salivary glands: a 20-year review with long-term follow-up. Ear Nose Throat J 84: 662664-7.
5. Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, et al. (2005) Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 23: 585-90.
6. Chen AM, Garcia J, Lee NY, Bucci MK, Eisele DW (2007) Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67: 988-94.
7. Laurie SA, Licitra L (2006) Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 24: 2673-8.
8. Carlson ER, Kim j, Mirowski GW, Stewart JCB, Zarbo RJ (2008) Salivary gland diseases. Oral Pathology: Clinical Pathology Correlations. Regezi JA, Sciubba JJ, Jordan RCK, eds. St. Louis, MI, USA: Saunders. pp 179-215.
9. He RG, Qiu WL, Zhou XJ (1986) The establishment of Acc-2 and Acc-3 and their morphological observation. J West China Stromatol 6: 1-3.
10. Guan XF, Qiu WL, He RG, Zhou XJ (1997) Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg 26: 116-9.
11. Shirasuna K, Watatani K, Furusawa H, Saka M, Morioka S, et al. (1990) Biological characterization of pseudocyst-forming cell lines from human adenoid cystic carcinomas of minor salivary gland origin. Cancer Res 50: 4139-45.
12. Tanaka N, Urabe K, Hashitani S, Sakurai K, Urade M (2007) Establishment and characterization of a human adenoid cystic carcinoma cell line forming colonies cultured in collagen gel and transplantable in nude mice. Oncol Rep 17: 335-40.
13. França CM, Jaeger MM, Jaeger RG, Araújo NS (2000) The role of basement membrane proteins on the expression of neural cell adhesion molecule (N-CAM) in an adenoid cystic carcinoma cell line. Oral Oncol 36: 248-52.
14. Li SL, Lin XP, Zhang KH (1990) Establishment of a human cancer cell line from adenoid cystic carcinoma of the minor salivary gland. Chin J Stomatol 25: 29-31.
15. Yang ML, Shen L, Sun CF (2006) Influence of LY294002 on protein kinase B expression in salivary adenoid cystic carcinoma (SACC)-83 and SACC-LM cells. Chin J Stomatol 41: 358-9.
16. Takata T, Kudo Y, Zhao M, Ogawa I, Miyauchi M, et al. (1999) Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis. Cancer 86: 928-35.
17. Choi S, Sano D, Cheung M, Zhao M, Jasser SA, et al. (2008) Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model. Clin Cancer Res 14: 5081-9. Erratum in (2009). Clin Cancer Res. 15: 416.
18. Lins AM, Micka KA, Sprecher CJ, Taylor JA, Bacher JW, et al. (1998) Development and population study of an eight-locus short tandem repeat (STR) multiplex system. J Forensic Sci 43: 1168-80.
19. Hu YC, Lam KY, Law SY, Wan TS, Ma ES, et al. (2002) Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 135: 120-7.
20. Parson W, Kirchebner R, Mühlmann R, Renner K, Kofler A, et al. (2005) Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J 19: 434-6.
21. Masters JR (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2: 315-9.
22. Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, et al. (2001) Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A 2001;98: 8012-7.
23. Gey GO, Coffman WD, Kubicek MT (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12: 264-5.
24. Hughes P, Marshall D, Reid Y, Parkes H, Gelber C (2007) The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 43: 575577-8, 581-2 passim.
25. Tanabe H, Takada Y, Minegishi D, Kurematsu M, Masui T, et al. (1999) Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304, and EJ-1/T24. Tissue Culture Research Communications 18: 329-338.
26. O'Toole CM, Povey S, Hepburn P, Franks LM (1983) Identity of some human bladder cancer cell lines. Nature 301: 429-30.
27. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T (1990) Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 26: 265-74.
28. Dirks WG, MacLeod RA, Drexler HG (1999) ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev Biol Anim 35: 558-9.
29. Brown J, Reading SJ, Jones S, Fitchett CJ, Howl J, et al. (2000) Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80: 37-45.
30. Suda K, Rothen-Rutishauser B, Günthert M, Wunderli-Allenspach H (2001) Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim 37: 505-14.
31. Harding MA, Arden KC, Gildea JW, Gildea JJ, Perlman EJ, et al. (2002) Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res 62: 6981-9.
32. Bubeník J, Baresová M, Viklický V, Jakoubková J, Sainerová H, et al. (1973) Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int J Cancer 11: 765-73.
33. Cooper JK, Sykes G, King S, Cottrill K, Ivanova NV, et al. (2007) Species identification in cell culture: a two-pronged molecular approach. In Vitro Cell Dev Biol Anim 43: 344-51.
34. Hebert PD, Ratnasingham S, deWaard JR (2003) Barcoding animal life: cytochrome c oxidase subunit 1 divergences among closely related species. Proc Biol Sci 270 Suppl 1: S96-9.
35. Parodi B, Aresu O, Bini D, Lorenzini R, Schena F, et al. (2002) Species identification and confirmation of human and animal cell lines: a PCR-based method. Biotechniques 2002;32: 432-4, 436, 438-40.
36. Markovic O, Markovic N (1998) Cell cross-contamination in cell cultures: the silent and neglected danger. In Vitro Cell Dev Biol Anim 34: 1-8.
37. MacLeod RA, Dirks WG, Matsuo Y, Kaufmann M, Milch H, et al. (1999) Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83: 555-63.
38. Azari S, Ahmadi N, Tehrani MJ, Shokri F (2007) Profiling and authentication of human cell lines using short tandem repeat (STR) loci: Report from the National Cell Bank of Iran. Biologicals 35: 195-202.
39. Gartler SM (1968) Apparent Hela cell contamination of human heteroploid cell lines. Nature 217: 750-1.
40. Chatterjee R (2007) Cell biology. Cases of mistaken identity. Science 315: 928-31.
41. Nelson-Rees WA, Daniels DW, Flandermeyer RR (1981) Cross-contamination of cells in culture. Science 212: 446-52.
42. Drexler HG, Dirks WG, Matsuo Y, MacLeod RA (2003) False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17: 416-26.
43. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD (2007) MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104: 13-9.
44. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, et al. (2008) Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93: 4331-41.
45. Nardone RM (2007) Eradication of cross-contaminated cell lines: a call for action. Cell Biol Toxicol 23: 367-72.
46. Lacroix M (2008) Persistent use of "false" cell lines. Int J Cancer 122: 1-4.
47. Glasel JA (1995) Validity of nucleic acid purities monitored by 260 nm/ 280 nm absorbance ratios. Biotechniques 18: 62-3.